Kangmei Pharmaceutical Co Ltd (600518) — Cash Flow Reinvestment Rate
Kangmei Pharmaceutical Co Ltd (600518) has a Cash Flow Reinvestment Rate of 0.22x as of September 2025, reinvesting CN¥48.57 Million (capex CN¥48.57 Million ) from operating cash flow of CN¥219.96 Million. Explore Kangmei Pharmaceutical Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kangmei Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2021)
Historical reinvestment intensity for Kangmei Pharmaceutical Co Ltd across 22 annual periods. Also explore Kangmei Pharmaceutical Co Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Kangmei Pharmaceutical Co Ltd (1999–2021)
Year-by-year capital reinvestment analysis for Kangmei Pharmaceutical Co Ltd. For live market cap and broader valuation context, see market cap of Kangmei Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.80x | CN¥171.64 Million | CN¥214.21 Million | CN¥171.63 Million | ▲ +173.9% |
| 2020 | 0.29x | CN¥301.74 Million | CN¥1.03 Billion | CN¥301.73 Million | ▲ +7.2% |
| 2019 | 0.27x | CN¥786.25 Million | CN¥2.88 Billion | CN¥473.20 Million | ▼ -98.2% |
| 2018 | 15.06x | CN¥4.60 Billion | CN¥305.62 Million | CN¥4.59 Billion | ▲ +1429.0% |
| 2016 | 0.99x | CN¥1.58 Billion | CN¥1.60 Billion | CN¥1.57 Billion | ▼ -63.8% |
| 2015 | 2.73x | CN¥1.39 Billion | CN¥508.86 Million | CN¥1.37 Billion | ▲ +352.4% |
| 2014 | 0.60x | CN¥682.06 Million | CN¥1.13 Billion | CN¥682.06 Million | ▲ +43.4% |
| 2013 | 0.42x | CN¥703.43 Million | CN¥1.67 Billion | CN¥703.43 Million | ▼ -69.8% |
| 2012 | 1.39x | CN¥1.41 Billion | CN¥1.01 Billion | CN¥1.41 Billion | ▼ -65.5% |
| 2011 | 4.04x | CN¥2.32 Billion | CN¥574.96 Million | CN¥2.32 Billion | ▲ +251.7% |
| 2010 | 1.15x | CN¥768.02 Million | CN¥669.19 Million | CN¥768.02 Million | ▼ -81.1% |
| 2009 | 6.06x | CN¥724.25 Million | CN¥119.47 Million | CN¥724.25 Million | ▼ -97.4% |
| 2008 | 229.90x | CN¥693.14 Million | CN¥3.02 Million | CN¥693.14 Million | ▲ +11285.6% |
| 2007 | 2.02x | CN¥328.23 Million | CN¥162.55 Million | CN¥328.23 Million | ▼ -66.6% |
| 2006 | 6.05x | CN¥413.45 Million | CN¥68.32 Million | CN¥413.45 Million | ▲ +3496.3% |
| 2005 | 0.17x | CN¥22.40 Million | CN¥133.13 Million | CN¥22.40 Million | ▼ -91.2% |
| 2004 | 1.91x | CN¥150.20 Million | CN¥78.52 Million | CN¥150.20 Million | ▲ +206.9% |
| 2003 | 0.62x | CN¥48.63 Million | CN¥78.02 Million | CN¥48.63 Million | ▼ -83.5% |
| 2002 | 3.79x | CN¥202.41 Million | CN¥53.47 Million | CN¥202.41 Million | ▼ -49.0% |
| 2001 | 7.43x | CN¥116.54 Million | CN¥15.69 Million | CN¥116.54 Million | ▲ +4442.5% |
| 2000 | 0.16x | CN¥1.63 Million | CN¥9.96 Million | CN¥1.63 Million | ▼ -61.8% |
| 1999 | 0.43x | CN¥12.96 Million | CN¥30.25 Million | CN¥12.96 Million | — |